2024 Oncologic Toxicity Management Symposium: A Multidisciplinary Approach — On Demand


2024 Oncologic Toxicity Management Symposium: A Multidisciplinary Approach — On Demand Banner



Date & Location
Thursday, August 1, 2024, 8:00 AM - Sunday, August 31, 2025, 11:00 PM

Specialties
Specialties - Allergy and Immunology, Cardiology, Dermatology, Dermatopathology, Emergency Medicine, Endocrinology, Diabetes and Metabolism, Gastroenterology, Gastrointestinal Oncology, Genitourinary Oncology, Geriatric Medicine, Gynecologic Oncology, Immunotherapy, Integrative Medicine, Medical Oncology, Neurology, Neuro-Oncology, Nurse Practitioner, Rheumatology, Solid Tumor Oncology

Overview

Memorial Sloan Kettering's 2024 Oncologic Toxicity Management (OTM) Symposium on demand, highlights a cutting-edge, multidisciplinary approach to managing adverse events associated with modern oncology treatments.

The increasing complexity of these treatments, coupled with the influence of genetic, biological, and environmental factors on toxicities, has made effective management a significant challenge. OTM employs advanced tools and techniques to identify individual differences and create personalized treatment plans. By offering evidence-based and tailored treatments for adverse events based on each patient's unique needs, this program aims to minimize the risk of additional toxicity. This approach contributes to improved quality of life, reduced morbidity, and consistent dosing of cancer therapies.

During this symposium, originally recorded live on June 20, 2024, participants will learn from experts at the forefront of OTM interventions, through didactic sessions covering OTM from bench to bedside and pre-recorded Q&A sessions.

This OTM Symposium cover a diverse range of topics, including:

  • Updates on Current Adverse Events Specific-Biological Targeted Therapies
  • The Role of Diet, Exercise, CBD, and Cannabis
  • Sexual Health, Psychosocial Health, and Fertility
  • Case Discussions on Challenging Cases of Patients with a Prior History of Autoimmune Disease and Treatment with Immune Checkpoint Inhibitors

For a complete list of presentations and speakers, please refer to the brochure from the live event.

Target Audience

This Symposium is intended for Physicians, Physician Assistants, Nurse Practitioners, Registered Nurses, Pharmacists, and other healthcare professionals treating cancer patients and their associated symptoms.

Objectives
At the conclusion of this program, learners will be able to:

  1. Evaluate new personalized strategies for preventing and managing treatment related toxicities
  2. Promote the translation of research findings into clinical practice
  3. Discuss non-pharmacological interventions for prevention of toxicities

Registration

Upon successful registration, head to the 'Course Content' tab at the top of the page to access course materials and instructions for claiming credit. This on demand program will be available for purchase until February 28, 2025. Paid participants will have access to the content, as well as the opportunity to claim credit, through March 31, 2025.

On Demand Access Fees

  • Physicians (MDs, PhDs, and DOs): $300
  • Advanced Practice Providers: $250
  • Nursing and Other Healthcare Professionals: $200
  • Residents, Fellows, and Students: $100 
  • MSK Employees: Complimentary

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information and to submit a request.

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.



Recorded/Review Date: June 20, 2024 | Original Release Date: August 1, 2024 | Termination Date: May 31, 2025